Clinical Trial Update: Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating losartan for reducing aortic dilatation in Marfan syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marfan Syndrome

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Marfan Syndrome | Phase 3 | Status: TERMINATED